Cyclic antithrombotic agents with non-RGD like activity
Trypou, P, Moussis, V, Malissiova, E, Chantzichristos, V.G, Tselepis, A.D, Tsikaris, V
Published in Atherosclerosis (01.07.2015)
Published in Atherosclerosis (01.07.2015)
Get full text
Journal Article
The administration of the synthetic peptide YMESRADR with a low aspirin dose significantly augments its antiplatelet effect, in contrast to the highly constrained peptide (S,S) PSRCDCR-NH2. An experimental study
Englezopoulos, K.V., Stathopoulou, E.M., Moussis, V., Chantzichristos, V.G., Papamichael, N.D., Tatsidou, P.T., Roussa, V.D., Tsoumani, M.E., Lakkas, L., Rammos, A., Katsouras, C.S., Fotou, E., Tsikaris, V., Tselepis, A.D., Michalis, L.K.
Published in Hellenic journal of cardiology (01.05.2022)
Published in Hellenic journal of cardiology (01.05.2022)
Get full text
Journal Article
The Effect Of Ticagrelor On Platelet-Endothelial Progenitor Cell Interaction
Sidiropoulou, S., Papadaki, S., Chantzichristos, V.G., Paschopoulos, M.E., Hansson, K.M., Tselepis, A.D.
Published in Atherosclerosis (01.08.2019)
Published in Atherosclerosis (01.08.2019)
Get full text
Journal Article